| Business Summary | | PharmaPrint
Inc.
was
formed
in
order
to
complete
the
development
of
and
commercialize
the
research
conducted
over
a
20-year
period
at
the
University
of
Southern
California
(USC)
School
of
Medicine.
PharmaPrint
uses
its
PharmaPrint
Process
technology
to
develop
high
quality
dietary
supplement,
functional
food
and
pharmaceutical
products
from
botanical
sources.
The
PharmaPrint
Process
technology
enables
the
Company
to
identify,
quantify
and
standardize
the
bioactives
within
plant
sources
that
are
believed
to
provide
therapeutic
benefits,
and
produce
products
having
consistent
batch-to-batch
quantities
and
ratios
of
these
bioactives. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | PharmaPrint,
Inc.,
a
development
stage
company,
develops
and
manufactures
pharmaceutical
versions
of
herbal
medicines
to
be
used
in
the
treatment
of
various
maladies.
For
the
six
months
ended
9/30/00,
revenues
decreased
99%
to
$13
thousand.
Net
loss
applicable
to
Common
decreased
80%
to
$3.5
million.
Revenues
reflect
the
absence
of
distribution
channels
to
market
products.
Net
loss
reflects
decreased
R&D
expenses
due
to
the
suspension
of
R&D
activities. | More
from
Market Guide: Significant
Developments |
| Officers | | | FY2000
Compensation | | Pay | Exer | |
| Steven Bowman, 55 CEO,
Principal Accounting Officer | -- | -- | Phillip Trad, 50 Pres,
Sec., Treasurer, Director | $240K | $85K | Dollar
amounts are as of 31-Mar-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|